Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Exercise or conversion Chief Scientific Officer acquired 7,218 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 1,400 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 1,400 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 1,400 shares (option exercise)
  5. 4 Exercise or conversion Chief Executive Officer acquired 1,400 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 1,400 shares (option exercise)
  7. 4 Exercise or conversion Director acquired 1,400 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 1,400 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $67.71 ($203,135)
  11. 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $66.57 ($665,747)
  12. 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $64.16 ($641,615)
  13. 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $67.68 ($203,032)
  14. 4 Open-market sale Chief Commercial Officer sold 10,000 shares at an average $67.01 ($670,050)
  15. 4 Open-market sale Chief Scientific Officer sold 9,000 shares at $65.00 ($585,000)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 18 of 38 · 758 filings